Deutsche Bank AG purchased a new position in Corteva, Inc. (NYSE:CTVA - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,957,501 shares of the company's stock, valued at approximately $250,471,000. Deutsche Bank AG owned approximately 0.44% of Corteva as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently bought and sold shares of CTVA. Arbejdsmarkedets Tillaegspension bought a new position in shares of Corteva in the 4th quarter worth about $23,679,000. Leonteq Securities AG acquired a new position in shares of Corteva in the 4th quarter valued at about $2,350,000. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Corteva by 23.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company's stock valued at $7,378,000 after buying an additional 20,957 shares during the last quarter. Brandes Investment Partners LP grew its position in shares of Corteva by 1.1% during the 4th quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company's stock valued at $155,009,000 after buying an additional 24,985 shares during the last quarter. Finally, Twin Capital Management Inc. raised its stake in Corteva by 178.9% during the fourth quarter. Twin Capital Management Inc. now owns 25,394 shares of the company's stock worth $1,702,000 after acquiring an additional 16,288 shares during the period. 81.54% of the stock is owned by institutional investors.
Corteva Stock Performance
Shares of CTVA stock opened at $77.97 on Wednesday. The firm has a market capitalization of $52.02 billion, a price-to-earnings ratio of 51.64, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97. The business has a 50 day simple moving average of $81.84 and a 200 day simple moving average of $80.12.
Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating analysts' consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analysts' expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company's revenue was down 1.2% on a year-over-year basis. During the same period in the previous year, the business earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva's dividend payout ratio (DPR) is 47.68%.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on CTVA shares. BNP Paribas Exane raised their target price on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. BMO Capital Markets upped their target price on Corteva from $95.00 to $100.00 and gave the company an "outperform" rating in a report on Monday, August 3rd. Zacks Research cut Corteva from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. raised their price target on Corteva from $77.00 to $83.00 and gave the stock a "neutral" rating in a report on Monday, August 3rd. Finally, Wells Fargo & Company upped their price objective on Corteva from $85.00 to $90.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 21st. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat, Corteva has a consensus rating of "Moderate Buy" and a consensus price target of $91.50.
Check Out Our Latest Report on Corteva
About Corteva
(
Free Report)
Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
